Singapore: Scientists at A*Star's Singapore Immunology Network (SIgN) have discovered a clue that has the potential to c...
Asia attracted a lot of interest from foreign multinational giants in the year 2013. This not only led to the increase i...
Singapore: To further strengthen its vaccine product pipeline, global drug giant Pfizer has inked a $130 million deal wi...
Singapore: Takeda Pharmaceutical has decided to consolidate its Vaccine Business Unit (VBU) operations by establishing g...
Singapore: Sanofi Pasteur, the vaccines division of Sanofi has published clinical study results of its dengue vaccine ca...
Virus-like particles (VLPs) are among the most exciting emerging vaccine technologies for generating effective and long-...
My journey as a scientist and a entrepreneur began with my strong interest in science and how it relates to health and w...
Singapore: An oral cholera vaccine, Shanchol, developed by Shantha Biotechnics and recommended by WHO has shown promise ...
Singapore: Global pharmaceutical company, Mylan, has run into a trouble for the presence of visible foreign material in ...
Singapore: Tergene Biotech, an Indian start up, has developed a promising vaccine candidate to combat pneumonia. The vac...
Singapore: WHO with the Health Ministry of Guinea, Médecins Sans Frontières (MSF), Epicentre and The Norwegian Ins...
Singapore: With rising measles cases in Queensland, Australian health authorities fear a severe outbreak, as 41 cases ha...
Singapore: The World Health organization recently certified Vietnam's vaccine management system as internationally stand...
Singapore: China biotech firm, Sinovac Biotech, has reported a decline of 31.6 percent in the first quarter of 2015, clo...
Singapore: Sinovac Dalian, subsidiary of China's Sinovac Biotech, has received China Food and Drug Administration approv...
Singapore: Hospira has issued a voluntary recall of one lot of preservative-free Bupivacaine HCl Injection, due to visib...
Singapore: Mylan is recalling a series of intravenous injection due to the presence of visible foreign particulate matte...
Singapore: China will remain the largest major hepatitis B market over the next decade, rising from just under $923 mill...
